Table 1.

General Characteristics of the 120 hCC Patients in Our Center

Variables		Number of Patients	Percentage of Patients (%)
Age	≥60y	45	37.5
	<60y	75	62.5
Sex	Female	26	21.7
	Male	94	78.3
Tumor size	Diameters <5cm	64	53.3
	Diameters ≥5cm	56	46.7
AFP	>20ng/mL	70	58.3
	≤20ng/mL	50	41.7
Multiple tumors (≥2)	Yes	39	32.5
	No	81	67.5
MVI	Yes	70	58.3
	No	50	41.7
Pathological stage	I	54	45
	II–IV	66	55
cirrhosis	Yes	92	76.7
	No	28	23.3
BCLC stage	A	100	83.3
	B	20	16.7
Viral hepatitis	Yes	103	85.8
	No	24	14.2
LN metastasis	Yes	12	10
	No	108	90
ALT	>80U/L	43	35.8
	≤80U/L	77	64.2
Total bilirubin	>1.0mg/dL (17.1μmol/L)	43	35.8
	≤1.0mg/dL (17.1μmol/L)	77	64.2
Albumin	<35g/L	22	18.3
	≥35g/L	98	81.7
Child-Pugh	A	120	100
	B	0	0
Post-operative TACE treatment	Yes	78	65
	No	42	35